Table I.
A, Patient characteristics
| ||||
---|---|---|---|---|
Parameter | No. | PLIN2 mRNA expression
|
P-value | |
Low (n=263) | High) (n=263 | |||
Age (years) | ||||
<60 | 243 | 140 | 103 | |
≥60 | 283 | 123 | 160 | 0.002 |
Sex | ||||
Female | 185 | 64 | 119 | |
Male | 341 | 199 | 144 | 0.000 |
T stage | ||||
T1 or T2 | 337 | 161 | 176 | |
T3 or T4 | 189 | 102 | 87 | 0.203 |
N stage | ||||
N0 or NX | 510 | 252 | 258 | |
N1 | 16 | 11 | 5 | 0.203 |
M stage | ||||
M0 or MX | 448 | 216 | 232 | |
M1 | 78 | 47 | 31 | 0.065 |
G grade | ||||
G1 or G2 | 246 | 119 | 126 | |
G3 or G4 | 280 | 144 | 137 | 0.541 |
TNM stage | ||||
I + II | 319 | 152 | 167 | |
III + IV | 207 | 111 | 96 | 0.211 |
| ||||
B, VHL status | ||||
| ||||
Parameter | No. | PLIN2 mRNA expression
|
P-value | |
Low (n=172) | High (n=171) | |||
| ||||
VHL alteration | ||||
Negative | 190 | 108 | 82 | |
Positive | 153 | 64 | 89 | 0.007 |
VH, von Hippel-Lindau; PLIN2, perilipin 2.